project id: TCGA-SKCM; case submitter id: TCGA-FS-A1ZB; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.2; age at index: 57; days to birth: -20963; days to death: 1486; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1945; year of death: 2006; age at diagnosis: 20963; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T3a; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2002; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3180; initial weight: 80.0; oct embedded: false; preservation method: Unknown; sample id: 323ff6ee-1901-4d6b-8fe5-0c9bb4b246d1; sample submitter id: TCGA-FS-A1ZB-06A; portion id: 6fd22c8e-2d20-47fd-98b8-1b8c9ff0e88b; portion submitter id: TCGA-FS-A1ZB-06A-12; slide id: a915306c-af04-4403-a17d-0db20bb6dd27; slide submitter id: TCGA-FS-A1ZB-06A-01-TS1; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 5.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 2.0; percent stromal cells: 8.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; section location: TOP;